These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36259647)

  • 1. Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis.
    Elfeki MA; Abdallah MA; Leggio L; Singal AK
    J Addict Med; 2023 Mar-Apr 01; 17(2):e119-e128. PubMed ID: 36259647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin.
    Singal AK; Leggio L; DiMartini A
    Liver Transpl; 2024 Feb; 30(2):200-212. PubMed ID: 37934047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of an Addiction Team in a Liver Transplantation Center.
    Donnadieu-Rigole H; Jaubert L; Ursic-Bedoya J; Hanslik B; Mura T; Gamon L; Faure S; Navarro F; Perney P; Herrero A; Pageaux GP
    Liver Transpl; 2019 Nov; 25(11):1611-1619. PubMed ID: 31529607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians.
    Shroff H; Gallagher H
    Clin Ther; 2023 Dec; 45(12):1177-1188. PubMed ID: 37813775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.
    Sharma P; Shenoy A; Shroff H; Kwong A; Lim N; Pillai A; Devuni D; Haque LY; Balliet W; Serper M
    Liver Transpl; 2024 Aug; 30(8):848-861. PubMed ID: 38471008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score.
    Lombardo-Quezada J; Colmenero J; López-Pelayo H; Gavotti C; Lopez A; Crespo G; Lopez E; Gual A; Lligoña A; Navasa M
    Liver Transpl; 2019 Aug; 25(8):1142-1154. PubMed ID: 30920118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse.
    Goswami A; Weinberg E; Coraluzzi L; Bittermann T; Nahas J; Addis S; Weinrieb R; Serper M
    Clin Transplant; 2024 Jul; 38(7):e15381. PubMed ID: 38940230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis.
    Alexandre W; Muhammad H; Agbalajobi O; Zhang G; Gmelin T; Adejumo A; Noll A; Jonassaint NL; DiMartini A; Bataller R; Rogal SS
    BMC Gastroenterol; 2023 Feb; 23(1):29. PubMed ID: 36732709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment With Low Rate of Relapse.
    Carrique L; Quance J; Tan A; Abbey S; Sales I; Lilly L; Bhat M; Galvin Z; Cattral M; Ghanekar A; McGilvray I; Reichman T; Sapisochin G; Sayed B; Selzner M; Lynch MJ; Selzner N
    Gastroenterology; 2021 Dec; 161(6):1896-1906.e2. PubMed ID: 34370999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.
    Khan A; Tansel A; White DL; Kayani WT; Bano S; Lindsay J; El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):191-202.e1-4; quiz e20. PubMed ID: 26256464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse.
    Daniel J; Dumortier J; Del Bello A; Gamon L; Molinari N; Faure S; Meszaros M; Ursic-Bedoya J; Meunier L; Monet C; Navarro F; Boillot O; Pageaux GP; Donnadieu-Rigole H
    JHEP Rep; 2023 Oct; 5(10):100832. PubMed ID: 37681206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival and predictors of relapse and survival after liver transplantation for alcoholic liver disease.
    Lindenger C; Castedal M; Schult A; Åberg F
    Scand J Gastroenterol; 2018 Dec; 53(12):1553-1561. PubMed ID: 30678557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.
    Im GY; Mellinger JL; Winters A; Aby ES; Lominadze Z; Rice J; Lucey MR; Arab JP; Goel A; Jophlin LL; Sherman CB; Parker R; Chen PH; Devuni D; Sidhu S; Dunn W; Szabo G; Singal AK; Shah VH
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2407-2416.e8. PubMed ID: 33069880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
    Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
    World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for and outcomes of liver transplantation in patients with alcohol-associated liver disease.
    Phillips PK; Caldis MW; Hristov AD; Lee AS; Lucey MR
    Minerva Gastroenterol Dietol; 2018 Jun; 64(2):126-137. PubMed ID: 29243894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoring systems to assess relapse risk in alcohol use disorder presenting for early liver transplantation: A systematic review.
    Shenoy A; Dienstag A; Dienstag P; Ford L; Schubert E; Wankoff M; Mohan K; Mirza O; Bhardwaj M; Im G
    Gen Hosp Psychiatry; 2021; 72():23-30. PubMed ID: 34229280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Allosio P; Amendola MF; Aricò S; Baselice A; Balbinot P; Campanile V; Fanucchi T; Macciò L; Meneguzzi C; Mioni D; Parisi M; Renzetti D; Rossin R; Gandin C; Bottaro LC; Caio G; Lungaro L; Zoli G; Scafato E; Caputo F
    Addict Biol; 2022 Jan; 27(1):e13090. PubMed ID: 34532923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.
    Herrick-Reynolds KM; Punchhi G; Greenberg RS; Strauss AT; Boyarsky BJ; Weeks-Groh SR; Krach MR; Anders RA; Gurakar A; Chen PH; Segev DL; King EA; Philosophe B; Ottman SE; Wesson RN; Garonzik-Wang JM; Cameron AM
    JAMA Surg; 2021 Nov; 156(11):1026-1034. PubMed ID: 34379106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease.
    Rogal S; Shenai N; Kruckenberg K; Rosenberger E; Dew MA; DiMartini A
    Alcohol Alcohol; 2018 Mar; 53(2):157-165. PubMed ID: 29293880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis: Efficacy and safety of baclofen in patients with alcohol use disorder co-morbid liver diseases.
    Duan F; Zhai H; Liu C; Chang C; Song S; Li J; Cheng J; Yang S
    J Psychiatr Res; 2023 Aug; 164():477-484. PubMed ID: 37441998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.